Skip to Navigation
London School of Hygiene & Tropical Medicine Malaria Centre

Research Groups and Consortia

 
 

Photograph courtesy of Lesong Conteh

Malaria Centre staff contribute to a number of research groups and consortia which are either held directly at LSHTM or with our collaborators. You can read more about some of these below:

ACT Consortium is a global research partnership formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

ACTwatch provides evidence-based recommendations for policy makers on how to increase availability of quality artemisinin-based combination therapies for malaria.

ARCTEC at LSHTM is a world-leading independent test centre for consultancy, and the evaluation and development of arthropod pest control technologies. We offer unique access to our internationally renowned scientists and experimental facilities. 

Drug Resistance Maps aims to map the geographical distribution of resistance mutations in African Plasmodium falciparum malaria.

Health Economics and Financing Programme produces and disseminates knowledge to improve the performance of developing country health systems.

Hospital for Tropical Diseases is the only National Health Service (NHS) Hospital dedicated to the prevention, diagnosis and treatment of tropical diseases and travel related infections.

ICEMR India is funded by the NIH. This consortium is part of the International Centers of Excellence for Malaria Research, a global network of independent research centres in malaria-endemic settings,  to provide the knowledge, tools, and evidence-based strategies crucial to understanding, controlling and ultimately preventing malaria.

Innovative Vector Control Consortium aims to overcome the barriers to innovation in the development of new insecticides for public health vector control and to develop information systems and tools which will enable new and existing pesticides to be used more effectively.

IPTi Decision-support tool is intended to aid national and sub-national policy makers in assessing whether Intermittent Preventive Treatment in infants is a locally appropriate intervention, by providing relevant information to support IPTi-related policy discussions.

Joint Malaria Programme is a joint collaborative link between the National Institute for Medical Research (NIMR) in Tanzania, Kilimanjaro Christian Medical Centre (KCMC) in Tanzania, London School of Hygiene and Tropical Medicine (LSHTM) in the UK, and the Centre for Medical Parasitology (CMP) at the University of Copenhagen in Denmark. Its mission is to conduct health research to alleviate disease burden in Tanzania.

LSHTM Analytical service provides analysis of the quality and level of antimalarial drugs as well as the amount of insecticide on bed nets.

LSHTM Malaria Repository provides a designated place for the storage of samples such as serum samples, DNA and blood spots.

MALACTRES is a consortium of researchers aiming to tackle multi-drug resistance in malaria under combination therapy.
With partners in Europe and Africa, the overall objective is to assess specific genetic markers in Plasmodium falciparum for associations with artemisinin combination therapy (ACT) resistance and to develop innovative, rapid and simple diagnostics
for malaria.

Malaria Atlas Project has assembled a unique spatial database of linked information based on medical intelligence and satellite-derived climate data to constrain the limits of malaria transmission and the largest ever archive of community-based estimates of parasite prevalence.

Malaria Capacity Development Consortium is supported by the Wellcome Trust and the Bill and Melinda Gates Foundation and is designed to help able and motivated African scientists undertake high-quality research that will enhance the research capacity of their home institutions.

Malaria Consortium is the world’s leading not-for-profit organisation dedicated to the control of malaria, we apply our depth of technical expertise and practical experience to develop smarter solutions that improve and save lives.

Malaria Elimination Group is a group of 48 international experts convened by the UCSF Global Health Group to elaborate the scientific, technical, operational, financial, and programmatic issues that countries need to consider when pursuing or embarking on malaria elimination.

MalariaGEN brings together research groups with different projects and scientific objectives to work together on large-scale investigations that depend on samples, data and expertise from multiple investigators.

Malaria in Pregnancy Consortium is a global research initiative of 47 research institutions, led by the Liverpool School of Tropical Medicine, undertaking a five year programme of research (2007-2012) to evaluate new and improved existing interventions for the prevention and treatment of malaria in pregnancy, which places up to 50 million women at risk every year.

Malaria Reference Laboratory is the national reference centre for malaria diagnosis in the UK that provides specialist diagnostics and speciation on malaria for NHS laboratories throughout the country. It is also the national centre for epidemiological monitoring of malaria and is an advisory service for complex questions on malaria.

Malaria Transmission Consortium will be used to establish an evidence base that can help malaria control program managers make informed decisions about monitoring malaria transmission and implementing or adjusting malaria control interventions across a broad range malaria transmission intensities.

Mobilize Against Malaria is Pfizer's signature philanthropic program to combat malaria. MAM is a five-year (2007–2011), $15M initiative announced at the Clinton Global Initiative in 2006, designed to address critical gaps in malaria treatment and education in Ghana, Senegal and Kenya.

MONKEYBAR is a 5 year project using an interdisciplinary network of researchers in the UK, the Philippines and Malaysia, to characterise the environment (socio-economic and natural) that supports P. knowlesi infection in its hosts and vectors, to determine the risk factors for exposure in humans and to inform and target control measures.

Using an interdisciplinary network of researchers in the UK, the Philippines and Malaysia, this work seeks to characterise the environment (socio-economic and natural) that supports P. knowlesi infection in its hosts and vectors, to determine the risk factors for exposure in humans and to inform and target control measures. - See more at: http://malaria.lshtm.ac.uk/research/projects/malaria-research-epidemiology-20#sthash.qXHkTxfw.dpuf
Using an interdisciplinary network of researchers in the UK, the Philippines and Malaysia, this work seeks to characterise the environment (socio-economic and natural) that supports P. knowlesi infection in its hosts and vectors, to determine the risk factors for exposure in humans and to inform and target control measures. - See more at: http://malaria.lshtm.ac.uk/research/projects/malaria-research-epidemiology-20#sthash.qXHkTxfw.dpuf
Using an interdisciplinary network of researchers in the UK, the Philippines and Malaysia, this work seeks to characterise the environment (socio-economic and natural) that supports P. knowlesi infection in its hosts and vectors, to determine the risk factors for exposure in humans and to inform and target control measures. - See more at: http://malaria.lshtm.ac.uk/research/projects/malaria-research-epidemiology-20#sthash.Z5S1DlpI.dpuf
Using an interdisciplinary network of researchers in the UK, the Philippines and Malaysia, this work seeks to characterise the environment (socio-economic and natural) that supports P. knowlesi infection in its hosts and vectors, to determine the risk factors for exposure in humans and to inform and target control measures. - See more at: http://malaria.lshtm.ac.uk/research/projects/malaria-research-epidemiology-20#sthash.Z5S1DlpI.dpuf

Pan African Malaria Vector Research Consortium was founded in 2008 as a consortium of three African vector control research sites specializing in the development and evaluation of malaria vector control products and interventions. The sites are located at Moshi and Muheza in Tanzania and in Cotonou, Benin.

Pathogen Genome Cluster Computing manages Genome scale data generation at LSHTM.

Worldwide Antimalarial Resistance Network is a global collaboration working to ensure that anyone affected by malaria receives effective and safe drug treatment.